WCN26-9500 Successful Transition from Eculizumab to Iptacopan in a Pediatric Case of C3 Glomerulopathy Refractory to Immunosuppressive Therapy
20260 citationsJournal Articlegold Open Access
Field-Weighted Citation Impact: 0.00
WCN26-9500 Successful Transition from Eculizumab to Iptacopan in a Pediatric Case of C3 Glomerulopathy Refractory to Immunosuppressive Therapy | Researchclopedia